1. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1;Andries;Antimicrob. Agents Chemother.,2004
2. E. Arnold, K. Das, A.D. Clark Jr., S.H. Hughes, X-ray crystal structure of R147681 (TMC120) complexed with HIV-1 reverse transcriptase, Personal communication, CABM Rutgers University, New Jersey, 1999
3. Roles of Conformational and Positional Adaptability in Structure-Based Design of TMC125-R165335 (Etravirine) and Related Non-nucleoside Reverse Transcriptase Inhibitors That Are Highly Potent and Effective against Wild-Type and Drug-Resistant HIV-1 Variants
4. From 4,5,6,7-tetrahydro-5-methylimidazo[4,5,1−jk](1,4)benzodiazepin-2-(1H)-one (TIBO) to etravirine (TMC125): Fifteen years of research on non-nucleoside inhibitors of HIV-1 reverse transcriptase;De Corte;J. Med. Chem.,2005
5. Inhibition of vaginal transmission of HIV-1 in hu-SCID mice by the non-nucleoside reverse transcriptase inhibitor TMC120 in a gel formulation;Di Fabio;AIDS,2003